Federal record
FDA Warning Letter issued June 8, 2026 · As of October 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →
We're providing this information based on regulatory filings Vial reviewed as of 2026-10-07. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →
Mint Med
Cincinnati, OH · Serves 36 states
Is this your company? Claim this profile.
Mint Med is a GLP-1 clinic available in 36 states. The FDA issued a warning letter involving Mint Med on June 8, 2026, with no close-out letter found resolving it. Pricing starts at about $106 per month, though total cost should be confirmed before signing up.
What they offerMental HealthGLP-1
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
Mint Med scores 38, in the Flagged band. The score moves when the public record changes.
Payment never changes a score.
Score history
- 38September 2026Record updated
- 86July 2026Vial scoring update
- 87June 2026Record updated
- 88June 2026Record updated: pricing
- 90June 2026Record updated
- 91June 2026Record updated
What we found on Mint Med
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, NPI registration, and LegitScript certification.
Mint Med is a telehealth weight-loss service that prescribes compounded semaglutide and tirzepatide in the 36 states their website lists as licensed. Semaglutide is listed at $106 a month and tirzepatide at $145, with all doses included. The pharmacies that fill their prescriptions go unnamed.
The FDA issued a warning letter involving Mint Med on June 8, 2026. We have not found a close-out letter resolving it as of our last check (October 7, 2026); read the details below before going further. The company serves 36 states. We also confirmed LegitScript certification, and the company appears in the federal NPI registry. Our findings reflect public records reviewed as of October 2026.
Why this score: 6 of 6 checks complete. Each links to the public source it was verified against.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed October 1, 2026.
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Amble has no federal action found; Mint Med has an FDA warning letter with no close-out letter found.
Mint Med scores 38, Amble scores 78.
Mint Med holds LegitScript certification; Amble does not.
Mint Med serves 36 states; Amble serves all 50 states.
| Mint Med | Amble | |
|---|---|---|
| Federal actions | Confirmed | None found |
| Vial Score | 38/100 | 78/100 |
| LegitScript certified | Yes | No |
| States served | 36 states | Nationwide (50 states) |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Treatments offered
Other GLP-1 providers in Vial
Other GLP-1 clinics in Vial’s directory. Open a profile, or compare side by side.
See 2 more alternativesShow fewer
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerMore GLP-1 providers
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.